Shares of CompuMed Inc. (OTCMKTS:CMPD – Get Free Report) traded up 0.2% on Wednesday . The company traded as high as $6.20 and last traded at $6.20. Approximately 950 shares changed hands during mid-day trading, an increase of 72% from the average session volume of 553 shares. The stock had previously closed at $6.19.
CompuMed Stock Performance
The company has a current ratio of 2.37, a quick ratio of 2.34 and a debt-to-equity ratio of 0.12. The stock’s 50 day moving average is $6.42 and its 200 day moving average is $5.50. The stock has a market capitalization of $8.25 million, a price-to-earnings ratio of -41.33 and a beta of -0.47.
CompuMed (OTCMKTS:CMPD – Get Free Report) last announced its earnings results on Monday, May 11th. The company reported ($0.06) earnings per share (EPS) for the quarter. The business had revenue of $2.03 million for the quarter. CompuMed had a negative return on equity of 6.47% and a negative net margin of 2.51%.
About CompuMed
CompuMed, Inc, an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. It offers telecardiology and teleradiology services that provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities worldwide. The company also provides enterprise telemedicine solutions; a suite of telecardiology services and diagnostic exam interpretations for pediatric and adult patients, including electrocardiogram (ECG) devices, echocardiogram, ECG, vascular, holter, nuclear, and video consults; and reading, transcription, reporting, storage, and video consultations in the areas of Vscan, X-ray, ultrasound, mammography, computed tomography, magnetic resonance imaging, and radiologist video consults.
Featured Stories
- Five stocks we like better than CompuMed
- AirJoule Unveils Prime System, Clearing Path to Commercialization
- Copper Stocks Are Getting a Bigger Spotlight as Gold’s Rally Cracks
- Nike Q4 Beat Masks Core Weakness as Analysts Cut Price Targets
- Uber’s Waymo Detour Tests the Stock’s Robotaxi Bull Case
Receive News & Ratings for CompuMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CompuMed and related companies with MarketBeat.com's FREE daily email newsletter.
